Asia · Regional markets · Yicai Global

Germany's Drug Price Reform Brings New Opportunities and Challenges to Chinese Drugmakers as Global Peers Reassess Investment

Published by Yicai Global · China 12 h ago

Roche has temporarily put all future investment decisions in Germany on hold due to local healthcare cost-cutting policies, Daniel Steiner, chief executive of the Swiss…

Read the full article on Yicai Global Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.yicaiglobal.com)

Also worth reading

Mint

Yes Bank shares extend decline to 26% in October, hit a multi-year low. Why are investors turning cautious?

CNBC-TV18

Q2 Results LIVE Updates: Vedanta Oil & Gas EBITDA jumps 66% QoQ; Suzlon Energy profit plunges 69% YoY

Tech in Asia

GoTo posts third straight profit

The Straits Times Business

Haomart founder halts foreclosure of his Jervois Hill GCB by OG

The Business Times

Hong Leong, TID place top bid of S$181.86 million or S$1,755 psf ppr for Orchard plot

Business Standard